Mallinckrodt’s Hepatorenal Syndrome Drug Terlipressin Gets A Virtual AdComm

 
• By Sue Sutter

US FDA cardiovascular and renal drugs panel will weigh approvability of the vasopressin analog during a nine-hour, online meeting 15 July; terlipressin was the focus of a 2009 complete response letter but met its primary endpoint in the recent CONFIRM trial.

Hepatorenal syndrome : are you at risk ? Yes or no
Terlipressin could become the first drug approved in the US for hepatorenal syndrome type 1. • Source: Shutterstock

More from US FDA Performance Tracker

More from Regulatory Trackers